Phosphatidylcholine Insulin Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing transdermal delivery systems are ineffective for large molecules like insulin due to the skin's porous structure, and they fail to maintain the stability and effectiveness of pharmaceuticals at ambient temperatures without refrigeration.
Innovation Solution
Formulating stabilized insulin compositions using a phosphatidylcholine carrier to entrap insulin, which enhances stability and transdermal delivery by forming a bilayer enveloping complex that maintains insulin's effectiveness at room temperature.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If transdermal delivery systems are used for insulin, then large molecule delivery is enabled, but the skin's porous structure prevents effective diffusion of insulin
Solution Approach 1:
Phosphatidylcholine serves as an intermediary substance that facilitates insulin transport through the skin. The phospholipid forms a carrier complex with insulin, enabling it to traverse the skin's porous structure effectively, thus resolving the contradiction between delivering large molecules and maintaining diffusion reliability
Solution Approach 2:
The invention creates a composite delivery system combining phosphatidylcholine and insulin in a specific formulation. This composite material leverages the properties of phosphatidylcholine to enable reliable transdermal delivery of insulin, overcoming the limitation of the skin's porous structure
2Ease of operation
If insulin is stored at ambient temperatures, then convenience for users is improved, but insulin denatures and loses effectiveness
Solution Approach 1:
Phosphatidylcholine acts as a protective intermediary that stabilizes insulin molecules at ambient temperatures. The phospholipid forms a protective complex around insulin, preventing denaturation and maintaining effectiveness without requiring refrigeration, thus resolving the contradiction between storage convenience and composition stability
Solution Approach 2:
The phosphatidylcholine formulation provides beforehand protection against thermal denaturation. By incorporating insulin into the phospholipid carrier system in advance, the formulation creates a protective environment that cushions insulin against temperature-related degradation, enabling stable storage at room temperature
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method allows for easier, more pleasant transdermal delivery of insulin and extends its shelf life, maintaining stability and effectiveness at room temperature, reducing the need for refrigeration and improving convenience for users.
Implementation Method 1
forming a bilayer enveloping complex that maintains insulin's effectiveness at room temperature
Implementation Method 2
mixing an insulin solution into the carrier to entrap said insulin within said carrier
Implementation Method 3
Topical drug delivery systems are known. These systems deliver drugs, therapeutic agents and other desired substances transdermally
Data Source
AI summary
A method of formulating insulin compositions comprises preparing a carrier having a phosphatidylcholine component which entraps insulin, stabilizing insulin compositions at room temperatures.